Study shows synergistic association between genetic and behavioral risks for liver disease

Upregulating TERT gene expression reverses multiple hallmarks of aging

Researchers at MD Anderson Cancer Center have demonstrated that therapeutically restoring ‘youthful’ levels of a specific subunit of the telomerase enzyme can significantly reduce the signs and symptoms of aging in preclinical models.

June 28, 2024

Vol.50 No.26

Clinical Trials & Tribulations

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

In May, the American Society of Clinical Oncology released guidelines on the use of germline genetic testing panels in concert with tumor testing for cancer patients. xxx:more

June 07, 2024

Vol.50 No.23

By Rebecca Sutphen

Clinical Trials & Tribulations

Are we focused on the wrong risk type in genetic screening?
Breast cancer screening study shows new paths to population screening

A common perception of genetic screening is that only individuals at high risk of certain diseases will be identified.

Eric Kmiec named editor in chief of Gene and Genome Editing

Eric Kmiec, executive director and chief scientific officer of ChristianaCare’s Gene Editing Institute, has been selected as editor-in-chief of the scientific journal Gene and Genome Editing. Kmiec previously served three years on the journal’s board.

September 15, 2023

Vol.49 No.34

Conversation with The Cancer Letter

Once deemed a “functional wasteland,” Y chromosome is found to play a role in cancer immunity
The finding may alter biology textbooks

Scientists used to dismiss the notion that the Y chromosome plays a role in cancer.

Yale scientists enable massively parallel DNA insertions into human cells

Yale Cancer Center scientists have developed a technology that enables massively parallel DNA substitutions (known as “knock-ins”) into human cells by taking advantage of messenger RNA, a platform now well-known from its use as the COVID vaccine vehicle.

February 03, 2023

Vol.49 No.05

Study shows synergistic association between genetic and behavioral risks for liver disease

YOU MAY BE INTERESTED IN

Upregulating TERT gene expression reverses multiple hallmarks of aging

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

Are we focused on the wrong risk type in genetic screening?
Breast cancer screening study shows new paths to population screening

Eric Kmiec named editor in chief of Gene and Genome Editing

Once deemed a “functional wasteland,” Y chromosome is found to play a role in cancer immunity
The finding may alter biology textbooks

Yale scientists enable massively parallel DNA insertions into human cells

Renew today!

Subscriber content

Login

Study shows synergistic association between genetic and behavioral risks for liver disease

YOU MAY BE INTERESTED IN

Upregulating TERT gene expression reverses multiple hallmarks of aging

Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists

Are we focused on the wrong risk type in genetic screening?Breast cancer screening study shows new paths to population screening

Eric Kmiec named editor in chief of Gene and Genome Editing

Once deemed a “functional wasteland,” Y chromosome is found to play a role in cancer immunityThe finding may alter biology textbooks

Yale scientists enable massively parallel DNA insertions into human cells

Login

Are we focused on the wrong risk type in genetic screening?
Breast cancer screening study shows new paths to population screening

Once deemed a “functional wasteland,” Y chromosome is found to play a role in cancer immunity
The finding may alter biology textbooks